Horizon Investments, LLC Gilead Sciences, Inc. Transaction History

Horizon Investments, LLC

$4.32 Billion
Q3 2024

A detailed history of Horizon Investments, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Horizon Investments, LLC holds 32,825 shares of GILD stock, worth $2.95 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

32,825

Previous 32,211 1.91%

Holding current value

$2.95 Million

Previous $2.21 Million 24.54%

% of portfolio

0.06%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $40,886 - $51,569	614 Added 1.91%	32,825 $2.75 Million
Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $22,291 - $25,726	353 Added 1.11%	32,211 $2.21 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $69,217 - $84,409	967 Added 3.13%	31,858 $2.33 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $306,854 - $347,980	4,188 Added 15.68%	30,891 $2.5 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $518,984 - $566,222	7,019 Added 35.66%	26,703 $2 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $212,828 - $242,760	-2,800 Reduced 12.45%	19,684 $1.52 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $1.29 Million - $1.47 Million	-16,707 Reduced 42.63%	22,484 $1.87 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $773,827 - $1.11 Million	12,417 Added 46.38%	39,191 $3.37 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $402,966 - $460,291	6,768 Added 33.83%	26,774 $1.65 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $223,953 - $252,238	-3,880 Reduced 16.24%	20,006 $1.24 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $141,846 - $177,748	-2,449 Reduced 9.3%	23,886 $1.42 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $1.18 Million - $1.34 Million	18,218 Added 224.44%	26,335 $1.91 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $25,925 - $27,970	383 Added 4.95%	8,117 $567,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $1.54 Million - $1.68 Million	-24,215 Reduced 75.79%	7,734 $533,000
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $1.92 Million - $2.19 Million	31,949 New	31,949 $2.07 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $489,229 - $557,453	-8,636 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $2.75 Million - $3.46 Million	-44,266 Reduced 83.68%	8,636 $546,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $2.98 Million - $3.46 Million	41,160 Added 350.54%	52,902 $4.07 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.6 Million - $2.05 Million	-25,529 Reduced 68.5%	11,742 $878,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.95 Million - $2.14 Million	31,584 Added 555.37%	37,271 $2.42 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $3.29 Million - $3.64 Million	-52,711 Reduced 90.26%	5,687 $360,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $29,883 - $33,510	483 Added 0.83%	58,398 $3.95 Million
Q1 2019 May 16, 2019	BUY	$62.53 - $70.05 $3.62 Million - $4.06 Million	57,915 New	57,915 $3.77 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.

Account

Horizon Investments, LLC Gilead Sciences, Inc. Transaction History